It is this part that is re-surfacing again that has me speculating on what has transpired as material event(s) and to which shareholders have not been witness:
wEaReLeGiOn referred to this in a previous post and it certainly seems that there was further (clinical?) trial activity that was not shared or made public imo.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.